Skip header and navigation

Narrow By

23 records – page 1 of 2.

Nova Scotia Health Authority. QEII. Cardiology. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1496
Available Online
View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Cardiology
Alternate Title
Brilinta
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Platelet Aggregation Inhibitors - therapeutic use
Adenosine - therapeutic use
Cardiovascular Diseases - prevention & control
Myocardial Infarction - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Adenosine
Anticoagulants (Medicine)
Cardiovascular system--Diseases--Prevention
Myocardial infarction--Prevention
Abstract
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Responsibility
Prepared by: Cardiology
Pamphlet Number
1496
Less detail

Fer injectable et insuffisance rénale chronique (IRC)

https://libcat.nshealth.ca/en/permalink/chpams37473
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2161
Available Online
View Pamphlet
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygè…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Injectable iron and chronic kidney disease (CKD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygène. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver.
This pamphlet is a French translation of the English pamphlet 1495, "Injectable Iron and Chronic Kidney Disease (CKD)". If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2161
Less detail

Tums (carbonate de calcium) et maladies rénales

https://libcat.nshealth.ca/en/permalink/chpams37499
Nova Scotia Health Authority. QEII. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2236
Available Online
View Pamphlet
Le médicament Tums (carbonate de calcium) permet de réguler le niveau de phosphore dans le corps. Ce dépliant explique pourquoi les personnes ayant des maladies rénales doivent prendre ce médicament, comment le prendre et le conserver, ainsi que ses effets secondaires possibles. ; This pamphlet is a French translation of the English pamphlet 1514, "Tums (Calcium Carbonate) and Kidney Disease". Tums (calcium carbonate) is a medicine used to treat high levels of phosphorus in the body. This pamph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Renal Program
Alternate Title
Tums (calcium carbonate) and kidney disease
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Calcium Carbonate - therapeutic use
Kidney Diseases - drug therapy
Subjects (LCSH)
Calcium carbonate
Kidneys--Diseases
Specialty
Nephrology
Abstract
Le médicament Tums (carbonate de calcium) permet de réguler le niveau de phosphore dans le corps. Ce dépliant explique pourquoi les personnes ayant des maladies rénales doivent prendre ce médicament, comment le prendre et le conserver, ainsi que ses effets secondaires possibles.
This pamphlet is a French translation of the English pamphlet 1514, "Tums (Calcium Carbonate) and Kidney Disease". Tums (calcium carbonate) is a medicine used to treat high levels of phosphorus in the body. This pamphlet explains why people with kidney disease need this medicine, how to take and store it, and a list of possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2236
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis patients

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1445
Available Online
View Pamphlet
People with kidney disease have a higher chance of having high potassium levels. High potassium levels may lead to an irregular heartbeat or cause problems with muscles and nerves. Kayexalate® is a drug that treats high potassium levels. This pamphlet explains how to take Kayexlate®, side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
People with kidney disease have a higher chance of having high potassium levels. High potassium levels may lead to an irregular heartbeat or cause problems with muscles and nerves. Kayexalate® is a drug that treats high potassium levels. This pamphlet explains how to take Kayexlate®, side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail

Cannabinoids for managing pain

https://libcat.nshealth.ca/en/permalink/chpams35259
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1350
Available Online
View Pamphlet
Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included. The French version of this pamphlet 1792, "Cannabinoïdes pour le traitement …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Specialty
Pain Management
Abstract
Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included. The French version of this pamphlet 1792, "Cannabinoïdes pour le traitement de la douleur", is also available.
Notes
Previous title: Cannabinoid analgesics for pain management
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1350
Less detail

Cannabinoïdes pour le traitement de la douleur

https://libcat.nshealth.ca/en/permalink/chpams35847
Nova Scotia Health Authority. Pain Management Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1792
Available Online
View Pamphlet
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une d…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pain Management Unit
Alternate Title
Cannabinoids for managing pain
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cannabinoids
Analgesics
Pain Management
Subjects (LCSH)
Cannabinoids
Analgesics
Pain--Treatment
Abstract
Les cannabinoïdes sont un groupe de médicaments parfois appelés « analgésiques à la marijuana » (antidouleurs) ou « cannabioïdes synthétiques » (artificiels). Ce dépliant explique pourquoi on vous a prescrit un cannabinoïde, la quantité et la façon de prendre ce médicament, les effets secondaires et la manière de rester en sécurité lorsque vous prenez ce médicament. Vous y trouverez également de l'information sur la conservation de ce médicament et sur ce qu'il faut faire en cas d'oubli d'une dose.
This pamphlet is a French translation of "Cannabinoid Analgesics for Pain Management" pamphlet 1350. Cannabinoids are a group of medications that are sometimes called ‘marijuana analgesics (painkillers)’ or ‘synthetic (artificial) cannabinoids’. This pamphlet explains why you have been prescribed a cannabinoid, how much of this medication to take and how to take it, side effects, and how to stay safe when taking this medication. Information on what to do if you miss a dose and how to store this medication is included.
Responsibility
Prepared by: Pain Management Unit
Pamphlet Number
1792
Less detail
Nova Scotia Health Authority. Nutrition and Food Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0543
Available Online
View Pamphlet
Flax is a gluten-free grain with a mild nutty flavour. Flax has many health benefits. This pamphlet explains the health benefits of flax, what forms flax comes in, how to use flax, how much to use, and how to store it. Nutrient information for the different types of flax and recipes are provided. Websites for further information are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nutrition and Food Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Flax
Subjects (LCSH)
Flax
Specialty
Food and Nutrition
Abstract
Flax is a gluten-free grain with a mild nutty flavour. Flax has many health benefits. This pamphlet explains the health benefits of flax, what forms flax comes in, how to use flax, how much to use, and how to store it. Nutrient information for the different types of flax and recipes are provided. Websites for further information are included.
Responsibility
Nutrition and Food Services
Pamphlet Number
0543
Less detail

Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2307
Available Online
View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Subjects (LCSH)
Kidneys--Diseases--Treatment
Specialty
Nephrology
Medications
Abstract
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2307
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Renal anemia
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0071
Available Online
View Pamphlet
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aspirin
Subjects (LCSH)
Aspirin
Specialty
Medications
Abstract
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0071
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0249
Available Online
View Pamphlet
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Anticoagulants
Subjects (LCSH)
Anticoagulants (Medicine)
Specialty
Medications
Abstract
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0249
Less detail

How to hand express breast/chest milk : Yarmouth Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams36580
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2004
Available Online
View Pamphlet
This pamphlet explains the steps to hand express breast/chest milk (take milk from your breasts/chest). It is also called "manual expressing". Hand expression takes practice. It is important to learn how to hand express breast/chest milk in the first hours after your baby is born. Hand expressing helps you make milk and helps your milk come in (also called milk let-down) when you first start to breast/chest feed your baby. A video is listed to help you with the basics. Instructions for how to s…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
How to manually express breast/chest milk : Yarmouth Regional Hospital
How to express breast/chest milk by hand : Yarmouth Regional Hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Breast Milk Expression - methods
Breast Feeding - methods
Subjects (LCSH)
Breast milk--Collection and preservation
Breastfeeding
Abstract
This pamphlet explains the steps to hand express breast/chest milk (take milk from your breasts/chest). It is also called "manual expressing". Hand expression takes practice. It is important to learn how to hand express breast/chest milk in the first hours after your baby is born. Hand expressing helps you make milk and helps your milk come in (also called milk let-down) when you first start to breast/chest feed your baby. A video is listed to help you with the basics. Instructions for how to store your breast/chest milk are also given.
Notes
Previous title: How to hand express breast milk : Yarmouth Regional Hospital
Responsibility
Prepared by: Women and Children's Health Unit, Yarmouth Regional Hospital
Pamphlet Number
2004
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amoun…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1468
Less detail

One-Alpha® (alfacalcidol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1470
Available Online
View Pamphlet
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can ca…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
One-Alpha® is a medication with the active ingredient alfacalcidol. This is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. Alfacalcidol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels of in the blood and weaker bones. One-Alpha® raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. One-Alpha® is a brand name for alfacalcidol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1470
Less detail

Calcium channel blockers

https://libcat.nshealth.ca/en/permalink/chpams35915
Nova Scotia Health Authority. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0295
Available Online
View Pamphlet
Calcium channel blockers are medications used to treat chest pain and contro high blood pressure. This pamphlet explains how to take and store calcium channel blockers, medications and foods to avoid, possible side effects, and warnings. Symptoms that require a trip to the nearest Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Calcium Channel Blockers
Chest Pain
Hypertension
Subjects (LCSH)
Calcium--Antagonists
Chest pain
Hypertension
Abstract
Calcium channel blockers are medications used to treat chest pain and contro high blood pressure. This pamphlet explains how to take and store calcium channel blockers, medications and foods to avoid, possible side effects, and warnings. Symptoms that require a trip to the nearest Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0295
Less detail

23 records – page 1 of 2.